Mumbai, July 22 (IANS) India’s pharmaceutical sector dipped notably on Wednesday after US President Donald Trump outlined a phased tariff plan on imported generic medicines, fuelling concerns over the long‑term outlook for drugmakers that rely heavily on US sales.The Nifty Pharma index fell nearly 2 per cent in early trade, making it the worst‑performing sectoral index on the National Stock Exchange in early trade.The Nifty Pharma index fell 1.85 per cent to 25,610 against Nifty, down 169 …
Trending
- Dastaar Movie Review: Tarsem Jassar’s Powerful Sikh Resilience Drama
- Diamond Made Man Part 2 Review: A Cosmic Sci-Fi Spectacle That Soars
- ‘Oka Court Case’ 2026 Movie Review: A Fresh Legal Love Drama That Wins Hearts
- Rahun Main Tere Rubaru Review: A Gripping Tale of Love, Danger & Deception
- ‘Vadala’ Movie Review: A Gripping Psychological Thriller With Powerhouse Performances
- Oh! Sukumari Movie Review: Thiruveer, Aishwarya Rajesh Spark Pure Magic in This Rural Entertainer
- MRP (Neekentha Naakentha) Movie Review: A Hilarious Corpse-Swap Comedy You Can’t Miss
- Arulvaan Movie Review: Arulnithi’s Powerful Drama Is a Heartfelt Ode to Education